Skip to content
zameds

Tenofovir alafenamide

Sold as Vemlidy, Venlamid, Tefumid, Tafnext, Tefonad

Loading the molecular structure
C21H29N6O5P476.50 g/mol

Propan-2-yl (2S)-2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-phenoxyphosphoryl]amino]propanoate

Drag to rotate. Structure from PubChem CID 9574768.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
3
Registrations
5

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Gilead Sciences South Africa (Pty) LtdVemlidy25mg520273Not determinedPIPIL
Cipla Medpro (Pty) LtdVenlamid, Tefumid25mg550089, 550090.089Not determinedPIPIL
Hetero Drugs South Africa (Pty) LtdTafnext, Tefonad25 mg580234, 580235.234Not determinedPIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Vemlidy

EACH TABLET CONTAINS: TENOFOVIR ALAFENAMIDE FUMARATE EQUIVALENT TO TENOFOVIR ALAFENAMIDE 25,0 mg

25mgFilm coated tablet52027352/20.2.8/0273Approved 19 June 2025RegisteredNot determinedPIPIL
Venlamid

EACH TABLET CONTAINS TENOFOVIR ALAFENAMIDE 25,0 mg

25mgTablet55008955/20.2.8/0089Approved 14 September 2021RegisteredNot determinedPIPIL
Tefumid

EACH TABLET CONTAINS TENOFOVIR ALAFENAMIDE 25,0 mg

25mgTablet550090.08955/20.2.8/0090.089Approved 14 September 2021RegisteredNot determinedPIPIL
Tafnext

EACH TABLET CONTAINS: TENOFOVIR ALAFENAMIDE HEMIFUMARATE EQUIVALENT TO TENOFOVIR ALAFENAMIDE 25,0 mg

25 mgFilm-coated tablets58023458/20.2.8/0234Approved 24 March 2026RegisteredNot determinedPIPIL
Tefonad

EACH TABLET CONTAINS: TENOFOVIR ALAFENAMIDE HEMIFUMARATE EQUIVALENT TO TENOFOVIR ALAFENAMIDE 25,0 mg

25 mgFilm-coated tablets580235.23458/20.2.8/0235.234Approved 24 March 2026RegisteredNot determinedPIPIL

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S4: Bictegravir

    Consolidated Schedules 06 July 2026, line 5495

  • S4: Dolutegravir

    Consolidated Schedules 06 July 2026, line 6100

  • S4: Emtricitabine

    Consolidated Schedules 06 July 2026, line 6178

  • S4: Rilpivirine

    Consolidated Schedules 06 July 2026, line 7808

  • S4: Tenofovir

    Consolidated Schedules 06 July 2026, line 8130

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsVemlidy, Gilead Sciences South Africa (Pty) LtdPatient information leaflet (PIL)For patients and carersVemlidy, Gilead Sciences South Africa (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles